據報快手-W(01024.HK)及抖音放寬銷售藥物准入門檻
內地傳媒報道,快手-W(01024.HK)日前發布《醫用保健-OTC(非處方藥)類目開放公告》,已於本月7日生效。根據公告,快手小店開放二級類目OTC(非處方藥)店舖准入。
早前抖音亦發布相關電商規則,8月更新《藥品類目管理規範》,當中入駐專營店門檻最低的要求,放寬至經營主體註冊資本不低於100萬、門店數量不小於20家。
報道指,隨著新版入駐要求的發布,大批連鎖藥店及藥企取得加入平台的資格,新興電商開展醫藥零售或有助藥品零售企業開展新市場增長點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.